-
·
Optimizing Quality of Life: Reducing Toxicity in Hodgkin Lymphoma Care
Optimizing Quality of Life: Reducing Toxicity in Hodgkin Lymphoma Care Dr. Andy Evens from Rutgers Cancer Institute discusses how to reduce the toxicity of Hodgkin’s lymphoma treatments so patients can live their best lives after cancer.
-
·
The Latest in Hodgkin Lymphoma: Treatment Options in 2024
The Latest in Hodgkin Lymphoma: Treatment Options in 2024 Where is Hodgkin lymphoma headed in 2024? Two-time Hodgkin’s survivor Dr. Sam Siegel discusses what patients and caregivers need to know with top lymphoma experts, Dr. Natalie Grover of UNC Health and Dr. Stephen Ansell of Mayo Clinic.
-
·
The Latest in Hodgkin Lymphoma
The Latest in Hodgkin Lymphoma Dr. Matthew Matasar, chief of blood disorders at the Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, discusses some of the most exciting news coming out of ASH 2023.
-
·
The Latest in Hodgkin Lymphoma Treatments
The Latest in Hodgkin Lymphoma Treatments: How to Talk to My Doctor About Options Matthew Matasar, MD, from Rutgers Cancer Institute and Hodgkin lymphoma survivors Samantha Siegel, MD, and Chelsey Gomez share the keys to effective communication with your doctors regarding treatment options, side effects, and the impact on your quality of life.
-
·
The Latest in Hodgkin Lymphoma
Matthew Matasar, MD, MS Dr. Matthew Matasar, chief of blood disorders at the Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, sat down with Dr. Samantha Spiegel, a Hodgkin’s lymphoma patient, to discuss some of the most exciting news coming out of ASH 2022.
